The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
The important tuberculosis drug pyrazinamide (PZA) is converted to its active form pyrazinoic acid (POA) in Mycobacterium tuberculosis (Mtb). Here the authors identify the pantothenate biosynthesis pathway enzyme aspartate decarboxylase (PanD) as the target of PZA and determine the POA bound Mtb Pan...
Guardado en:
Autores principales: | Qingan Sun, Xiaojun Li, Lisa M. Perez, Wanliang Shi, Ying Zhang, James C. Sacchettini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/169473de3b71419aa5a136c2eae1f753 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis
por: S. M. Ramirez-Busby, et al.
Publicado: (2017) -
Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide
por: Pierre Santucci, et al.
Publicado: (2021) -
PanM, an Acetyl-Coenzyme A Sensor Required for Maturation of <sc>l</sc>-Aspartate Decarboxylase (PanD)
por: Tara N. Stuecker, et al.
Publicado: (2012) -
PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS
por: R. M. Anthony, et al.
Publicado: (2018) -
Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
por: Edgar A Florentini, et al.
Publicado: (2020)